Catalyst Funds Management Pty Ltd Cuts Holdings in GRAIL, Inc. $GRAL

by · The Cerbat Gem

Catalyst Funds Management Pty Ltd reduced its position in GRAIL, Inc. (NASDAQ:GRAL – Free Report) by 47.0% during the second quarter, Holdings Channel.com reports. The institutional investor owned 8,200 shares of the company’s stock after selling 7,281 shares during the period. Catalyst Funds Management Pty Ltd’s holdings in GRAIL were worth $422,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in GRAL. Teacher Retirement System of Texas grew its holdings in GRAIL by 5.5% during the 2nd quarter. Teacher Retirement System of Texas now owns 8,538 shares of the company’s stock valued at $439,000 after buying an additional 447 shares in the last quarter. Parallel Advisors LLC boosted its position in shares of GRAIL by 24.1% during the 2nd quarter. Parallel Advisors LLC now owns 2,313 shares of the company’s stock valued at $119,000 after acquiring an additional 449 shares during the last quarter. Crown Wealth Group LLC grew its holdings in shares of GRAIL by 5.9% in the second quarter. Crown Wealth Group LLC now owns 8,986 shares of the company’s stock valued at $462,000 after purchasing an additional 500 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in GRAIL by 28.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,835 shares of the company’s stock worth $76,000 after purchasing an additional 623 shares during the last quarter. Finally, HighTower Advisors LLC raised its stake in GRAIL by 5.7% during the first quarter. HighTower Advisors LLC now owns 11,591 shares of the company’s stock valued at $296,000 after purchasing an additional 627 shares in the last quarter.

Analyst Upgrades and Downgrades

GRAL has been the subject of a number of recent research reports. Weiss Ratings reissued a “sell (d-)” rating on shares of GRAIL in a research note on Wednesday, October 8th. Canaccord Genuity Group lifted their price target on GRAIL from $85.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, November 17th. Guggenheim raised GRAIL from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Wednesday, November 12th. Finally, UBS Group set a $75.00 price objective on GRAIL in a research note on Friday, October 3rd. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, GRAIL currently has an average rating of “Hold” and an average price target of $75.00.

Get Our Latest Analysis on GRAL

Insider Buying and Selling at GRAIL

In other news, President Joshua J. Ofman sold 6,114 shares of the business’s stock in a transaction on Thursday, October 16th. The shares were sold at an average price of $82.01, for a total transaction of $501,409.14. Following the completion of the sale, the president directly owned 381,818 shares of the company’s stock, valued at approximately $31,312,894.18. The trade was a 1.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Robert P. Ragusa sold 7,239 shares of the company’s stock in a transaction dated Wednesday, October 15th. The stock was sold at an average price of $68.88, for a total transaction of $498,622.32. Following the completion of the transaction, the chief executive officer owned 727,388 shares in the company, valued at approximately $50,102,485.44. The trade was a 0.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 113,295 shares of company stock valued at $7,380,888. Corporate insiders own 1.85% of the company’s stock.

GRAIL Price Performance

Shares of NASDAQ:GRAL opened at $93.55 on Friday. The firm has a market capitalization of $3.65 billion, a PE ratio of -8.04 and a beta of 4.31. The business has a 50 day simple moving average of $71.79 and a two-hundred day simple moving average of $50.01. GRAIL, Inc. has a 1 year low of $15.96 and a 1 year high of $103.00.

GRAIL (NASDAQ:GRAL – Get Free Report) last issued its quarterly earnings results on Wednesday, November 12th. The company reported ($2.46) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($3.40) by $0.94. The firm had revenue of $36.19 million during the quarter, compared to analyst estimates of $33.83 million. GRAIL had a negative return on equity of 15.69% and a negative net margin of 286.43%. Equities research analysts expect that GRAIL, Inc. will post -15.15 EPS for the current fiscal year.

GRAIL Company Profile

(Free Report)

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.

Featured Stories

Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GRAIL, Inc. (NASDAQ:GRAL – Free Report).